Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Cancer. 2017 Dec 01; 123(23):4566-4573.